One FTC tumor with a TP53 alteration, one OTC tumor with TERT promoter + PIK3CA + EIF1AX alterations, and one OTC tumor with a TERT promoter alteration were classified as non-aggressive on surgical pathology. The gene discussed is TP53; the disease is neoplasm.